GENERIC SALES MAY JUMP 15% WORLDWIDE IN 2008

JANUARY 01, 2008

According to the latest forecast from researchers at IMS Health, sales of generic pharmaceuticals are on track to rise 14% to 15% next year to a record $70 billion worldwide. Many of the leading manufacturers of generic medicines will continue to make inroads in emerging markets such as China, Brazil, Mexico, and Turkey. Since these countries cannot afford cutting-edge innovative pharmaceuticals, IMS predicts that much of the growth will be in the demand for cheaper generics.

As the generic-drug industry prepares for a feast next year, however, the branded counterparts are expecting famine. IMS researchers predict that global sales for brand pharmaceuticals will rise only 6% to 7% in 2008, while sales in the United States and Europe will rise just 4% to 5%.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.